Dr. Ghassan El-Haddad is the Head of the Radionuclide Therapy Program at H. Lee Moffitt Cancer Center and Research Institute. He is an Associate Member in Interventional Radiology and Cancer Physiology at Moffitt Cancer Center, and an Associate Professor of Radiology and Oncologic Sciences at the University of South Florida in Tampa, FL.
He is board certified by the American Board of Nuclear Medicine, and the American Board of Interventional Radiology/Diagnostic Radiology.
He is an active member of multiple medical societies, including the SIO, SIR, RSNA, NANETS, and SNMMI. He is a member of the board of directors of the NANETS, and member of the Therapy Center of Excellence and Targeted Radioisotope Therapy outreach working group for the SNMMI. He is a principal investigator and co-investigator on several phase I/II, and phase III multicenter randomized clinical trials on Liver-directed Embolotherapy, and Radiopharmaceutical Therapy.